Resources

Bionical Emas Introduces AI Strategy

Technology is evolving at an unprecedented pace, and artificial intelligence (AI) is at the forefront of this transformation. Bionical Emas is excited about the opportunities AI presents to enhance the service it delivers to patients, healthcare professionals, and clients. Integrating advanced technology is allowing Bionical Emas to focus its energies on providing an even greater human element, accelerating its mission to bring life-changing medicines to patients around the world. For further information please email info@bionicalemas.com

The Patient Voice Podcast - Episode 4: A Treating Physicians Perspective on Collecting Real World Data from Early Access Programs

In this episode, we are joined by leading expert Giovanni Baranello, a professor of paediatric neuromuscular disorders at Great Ormond Street Hospital Institute of Child Health, London. In his fast-paced role he manages competing clinical priorities involving the diagnosis and clinical management of children with different neuromuscular conditions. Professor Baranello gives his unique perspective and insight into Real World Data collection from Early Access Programs.

The Patient Voice Podcast - Episode 3: How Patient Voices Contribute to Equality and Diversity in Clinical Development

In this episode, we hear from two people who have lived experiences in advocating for their ethnicity, race, gender, and communities. They discuss their personal journeys and what led them to advocate for others to improve equality and diversity in today's clinical development landscape. Our host, Naomi Litchfield - Director of Patient Advocacy at Bionical Emas, speaks to Dr Sondra Butterworth, psychologist and founder of RareQOL, and Alfred Samuels, author, patient advocate and prostate cancer survivor. They discuss everything from accessibility and language barriers to mental health and the value of community, demonstrating the importance of how the patient voice can contribute to true equality and diversity.

Navigating Real-World Data Collection From Early Access Programs in the UK: An Underutilized Opportunity

Navigating Real-World Data Collection From Early Access Programs in the UK: An Underutilized Opportunity

Applying a Decision-Making Framework for Expanded Access to Duchenne Muscular Dystrophy

Applying a Decision-Making Framework for Expanded Access to Duchenne Muscular Dystrophy

The Patient Voice Podcast - Episode 2: How can patient insights provide an informed voice for access to medicines?

This episode of The Patient Voice explores the myriad of ways in which patients’ personal experiences, perspectives, and preferences can provide an informed voice for access to medicines.

World Lung Cancer Day Infographic

Lung cancer is the leading cause of cancer deaths worldwide, claiming more lives yearly than colon, breast, and liver cancers combined.

Johnson & Johnson Guide to Expanded Access

Expanded Access offers a potential pathway to investigational treatment for patients who are ineligible to participate in clinical trials and have exhausted all available treatment options. The Johnson & Johnson Guide provides patients, their caregivers, and their physicians with much-needed clarity around their options at a moment when the power of information cannot be underestimated. Bionical Emas is proud to have collaborated on this first-of-its-kind Guide.

What is an Early Access Program?

What is Real World Data?

What is a Clinical Trial?

Access to medicines: What you need to know

Naomi Litchfield, Director of Patient Advocacy at Bionical Emas, spoke to Laura Smith van Carroll, MMSc Head of Insight & Advocacy at Metabolic Support UK to share her thoughts and insights on what to expect as a metabolic patient and family when joining a clinical trial.